Why is semaglutide not available?

Semaglutide is a relatively new drug that was approved by the FDA in 2017. It is an injectable prescription medication used to improve blood sugar levels in adults with type 2 diabetes.
There are a few key reasons why semaglutide may not be widely available yet:

In summary, while semaglutide represents an exciting new class of diabetes medications known as GLP-1 receptor agonists, availability is limited by factors like production challenges, regulatory approvals, intellectual property protections, and reimbursement hurdles. As these issues are resolved over the next several years, the expectation is semaglutide will become much more widely accessible to patients.

If you are interested in accessing semaglutide or other innovative diabetes treatments, Hormone Wellness Institute has endocrinology experts on staff who can determine if it is appropriate for your health needs. We offer convenient telemedicine consults and can provide guidance on insurance coverage and affordability options.

Other GLP-1 receptor agonists similar to semaglutide that you may wish to discuss with your doctor include:

These medications can be excellent options for many patients with type 2 diabetes, with data showing they can:

Our clinic offers all the leading GLP-1 receptor agonists so patients have access to these impactful therapies. We handle everything from prescribing to delivery right to your door through our national pharmacy network.

I hope this breakdown gives some helpful perspective on the current landscape for semaglutide availability. Please consult your physician to determine if treatment with a GLP-1 receptor agonist is appropriate for your diabetes management. Hormone Wellness Institute has specialists ready to guide you towards better health.

Get Free Consultation